We asked startup founders, recruiters, and hiring managers what to do — and not to do — to boost your chances of getting an offer.

Microsoft Threat Intelligence identified an active multi-stage intrusion campaign targeting hospitality organizations in ...

Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, announced today that the U.S. Food ...

The Post tested ChatGPT, Gemini and other chatbots with political questions, and the results show that the AI tools have ...

Mastra AI’s 144 JavaScript packages was executed in just 88 minutes by North Korea’s Sapphire Sleet hacking group, which ...

Microsoft Threat Intelligence analyzed a cryptocurrency clipper campaign that combines clipboard theft, wallet replacement, ...

REPL shares soared 85.7% after FDA alignment on RP1 plus Opdivo BLA resubmission plans. Replimune plans to resubmit the BLA in the coming days. The FDA intends to prioritize review. The RP1 plus ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Replimune Group, Inc.'s RP1 has failed at the FDA twice, but Makary's resignation keeps a resubmission possible. REPL's cash runway stands at under a year; workforce cuts and RP1 discontinuation are ...

This project is a proof-of-concept that runs a JavaScript engine inside a web browser by compiling it to WebAssembly. The engine is Goja — a pure-Go implementation of ECMAScript 5.1 — and the ...

Replimune (REPL) has announced that it has no other option but to reduce its workforce and scale back U.S. manufacturing operations after the FDA on Friday declined to approve its lead asset, RP1, ...